Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学BCMA-Targeted Myeloma Therapy

Saad Usmani

MD, MBA

🏢Memorial Sloan Kettering Cancer Center🌐USA

Chief, Myeloma Service

68
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Saad Usmani is a global leader in myeloma clinical research who has been instrumental in the CARTITUDE program evaluating cilta-cel. His work has advanced BCMA-targeted therapy from late-line to earlier treatment settings, and he leads MRD-driven treatment strategies. He has contributed to establishing international standards for myeloma response assessment.

Share:

🧪Research Fields 研究领域

Cilta-cel CARTITUDE
BCMA CAR-T
Myeloma frontline therapy
MRD-driven treatment
Global myeloma trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Saad Usmani 的研究动态

Follow Saad Usmani's research updates

留下邮箱,当我们发布与 Saad Usmani(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment